The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Semigolovskiy N.Yu.
Sokolov North-Western District Scientific Clinical Center;
Saint Petersburg State University
Lobachenko I.G.
Sokolov North-Western District Scientific Clinical Center
Simutis I.S.
Sokolov North-Western District Scientific Clinical Center;
Mechnikov North-Western State Medical University
Danilov M.S.
Sokolov North-Western District Scientific Clinical Center;
Mechnikov North-Western State Medical University
Ratnikov V.A.
Sokolov North-Western District Scientific Clinical Center;
Saint Petersburg State University
Enkina T.N.
Sokolov North-Western District Scientific Clinical Center;
Inozemtsev Academy of Medical Education
Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coronary intervention
Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2025;18(2): 191‑200
Read: 222 times
To cite this article:
Semigolovskiy NYu, Lobachenko IG, Simutis IS, et al. . Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coronary intervention. Russian Journal of Cardiology and Cardiovascular Surgery.
2025;18(2):191‑200. (In Russ.)
https://doi.org/10.17116/kardio202518021191
To study modern strategies for pharmacological treatment and prevention of reperfusion-ischemia syndrome in percutaneous coronary intervention.
Literature data were searched in the PubMed, Google Scholar and eLibrary databases.EN in accordance with PRISMA principles (Preferred Reporting Items for Systematic Reviews and Meta-Analyses).
We found numerous strategies for treatment and prevention of reperfusion-ischemia syndrome in percutaneous coronary intervention. However, there is no a single technique ensuring absolute effectiveness. Various approaches, such as antioxidants, medications improving microcirculation and even innovative methods are actively being developed. However, their results can vary depending on characteristics of patients, degree of ischemia and other concomitant factors.
The number of clinical studies devoted to cardiac protection during percutaneous coronary intervention significantly increased in recent years. This indicates high interest of medical community in the study of reperfusion-ischemia syndrome.
Keywords:
Authors:
Semigolovskiy N.Yu.
Sokolov North-Western District Scientific Clinical Center;
Saint Petersburg State University
Lobachenko I.G.
Sokolov North-Western District Scientific Clinical Center
Simutis I.S.
Sokolov North-Western District Scientific Clinical Center;
Mechnikov North-Western State Medical University
Danilov M.S.
Sokolov North-Western District Scientific Clinical Center;
Mechnikov North-Western State Medical University
Ratnikov V.A.
Sokolov North-Western District Scientific Clinical Center;
Saint Petersburg State University
Enkina T.N.
Sokolov North-Western District Scientific Clinical Center;
Inozemtsev Academy of Medical Education
Received:
28.01.2025
Accepted:
20.02.2025
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.